Home NDC 0378-4105 Abacavir Sulfate
Product NDC 0378-4105
11-digit product format 003784105
Labeler code 0378
Product ID 0378-4105_3ae56d4c-73b4-497f-bc93-554a247f2359
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name abacavir sulfate
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Mylan Pharmaceuticals Inc.
Application ANDA091294
Marketing category ANDA
Marketing start 2012-06-19
Substance ABACAVIR SULFATE
Active strength 300 mg/1
Pharmacologic classes Cytochrome P450 1A1 Inhibitors [MoA], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A091294-001 ABACAVIR SULFATE ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A091294-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A091294-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2012-06-18 cb3db0bc1861…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 41 observed states.
openFDA label cross-check# Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
Matched openFDA labels page 1 of 1 · 3 matching rows.
Additional Listing Data#
Finished product Yes
Brand name base Abacavir Sulfate
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ABACAVIR SULFATE 300 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination J220T4J9Q2 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 242679 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0378-4105-91 Abacavir Sulfate 60 in 1 BOTTLE, PLASTIC TABLET, FILM COATED 60 12 0378-4105-91 Abacavir Sulfate 1 in 1 CARTON TABLET, FILM COATED 1 12
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded ABACAVIR SULFATE ACTIVE INGREDIENT J220T4J9Q2 ABACAVIR SULFATE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.] 8 ABACAVIR ACTIVE MOIETY WR2TIP26VS ABACAVIR SULFATE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.] 8 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U ABACAVIR SULFATE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.] 8 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 ABACAVIR SULFATE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.] 8 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT ABACAVIR SULFATE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.] 8 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO ABACAVIR SULFATE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.] 8 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 ABACAVIR SULFATE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.] 8 POLYETHYLENE GLYCOLS INACTIVE INGREDIENT 3WJQ0SDW1A ABACAVIR SULFATE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.] 8 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 ABACAVIR SULFATE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.] 8 SODIUM STARCH GLYCOLATE TYPE A POTATO INACTIVE INGREDIENT 5856J3G2A2 ABACAVIR SULFATE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.] 8 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP ABACAVIR SULFATE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.] 8 ABACAVIR SULFATE ACTIVE INGREDIENT J220T4J9Q2 ABACAVIR SULFATE TABLET, FILM COATED [MYLAN INSTITUTIONAL INC.] 3 ABACAVIR ACTIVE MOIETY WR2TIP26VS ABACAVIR SULFATE TABLET, FILM COATED [MYLAN INSTITUTIONAL INC.] 3 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U ABACAVIR SULFATE TABLET, FILM COATED [MYLAN INSTITUTIONAL INC.] 3 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 ABACAVIR SULFATE TABLET, FILM COATED [MYLAN INSTITUTIONAL INC.] 3 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT ABACAVIR SULFATE TABLET, FILM COATED [MYLAN INSTITUTIONAL INC.] 3 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO ABACAVIR SULFATE TABLET, FILM COATED [MYLAN INSTITUTIONAL INC.] 3 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 ABACAVIR SULFATE TABLET, FILM COATED [MYLAN INSTITUTIONAL INC.] 3 POLYETHYLENE GLYCOLS INACTIVE INGREDIENT 3WJQ0SDW1A ABACAVIR SULFATE TABLET, FILM COATED [MYLAN INSTITUTIONAL INC.] 3 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 ABACAVIR SULFATE TABLET, FILM COATED [MYLAN INSTITUTIONAL INC.] 3 SODIUM STARCH GLYCOLATE TYPE A POTATO INACTIVE INGREDIENT 5856J3G2A2 ABACAVIR SULFATE TABLET, FILM COATED [MYLAN INSTITUTIONAL INC.] 3 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP ABACAVIR SULFATE TABLET, FILM COATED [MYLAN INSTITUTIONAL INC.] 3 ABACAVIR SULFATE ACTIVE INGREDIENT J220T4J9Q2 ABACAVIR SULFATE TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] 1 ABACAVIR ACTIVE MOIETY WR2TIP26VS ABACAVIR SULFATE TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] 1 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U ABACAVIR SULFATE TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] 1 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 ABACAVIR SULFATE TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] 1 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT ABACAVIR SULFATE TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] 1 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO ABACAVIR SULFATE TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] 1 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 ABACAVIR SULFATE TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] 1 POLYETHYLENE GLYCOLS INACTIVE INGREDIENT 3WJQ0SDW1A ABACAVIR SULFATE TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] 1 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 ABACAVIR SULFATE TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] 1 SODIUM STARCH GLYCOLATE TYPE A POTATO INACTIVE INGREDIENT 5856J3G2A2 ABACAVIR SULFATE TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] 1 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP ABACAVIR SULFATE TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0378-4105 ABACAVIR SULFATE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.] 12 Current NDC, Legacy NDC, 2 package rows 20250115_5676d391-f9a4-44be-9604-954b3d8d0e2b.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 0378-4105-91 00378410591 1 BOTTLE, PLASTIC in 1 CARTON (0378-4105-91) / 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC 2012-06-19 0000-00-00 No No Current